Patients with type 2 diabetes face many challenges, including blood sugar monitoring, maintaining a healthy diet and transitioning to new therapies. Novo Nordisk (NYSE: NVO), the world's largest maker of insulin, is committed to helping new patients make the move to insulin. As part of that commitment, the company is announcing its Levemir® Satisfaction Guarantee for U.S. patients taking Levemir® (insulin detemir [rDNA origin] injection) to treat type 2 diabetes.
First-time insulin users have... read more
Submitted by Avera
Many people are perplexed by the wide-ranging dosages given to insulin-injecting diabetics. You may be asking, “What is the normal dose of insulin?” Actually, there is no normal dose of insulin, according to the American Diabetes Association. Some bodies are very resistant to insulin and require higher doses. Your own insulin requirement fluctuates depending on your health, physical activity and eating habits. To evaluate your insulin dose, first estimate the amount of insulin you would... read more
Submitted by Gabby
Insulin therapy in patients with newly diagnosed type 2 diabetes may have benefits beyond improved glycemic control. Several studies have suggested that early insulin therapy may improve beta-cell function. Many of us have observed this in clinical practice.
In the October 2008 issue of Diabetes Care, Chen et al reported the results of a study comparing the effects of insulin to oral antidiabetic agents on new onset type 2 diabetes with severe hyperglycemia (fasting plasma... read more
Submitted by Avera
SmartInsulin is the idea of Dr Todd Zion, the CEO of SmartCells, Inc., a biotechnology company based in the USA. The concept is simple - deliver insulin in such a way that it is only released into the blood stream when it is needed. The new approach involves using a plant-derived protein that can bind and release insulin in response to glucose levels.
The theory is that SmartInsulin could be formulated so that people... read more
Submitted by Avera
HealthDay News) -- An insulin pump offers many benefits for diabetics, including better blood glucose control and greater convenience.
The American Diabetes Association offers these suggestions while getting used to your pump:
Take your insulin at the same time each day.
Carry an extra insulin pen or additional insulin with you when traveling.
Talk to a dietitian about how to adjust your diet when you start using the pump.
When you turn... read more
Submitted by Deleted User
PhD student at Sydney's Garvan Institute of Medical Research has uncovered an important piece in the puzzle of how insulin works, a problem that has plagued researchers for more than 50 years. This finding brings us one step closer to explaining exactly how insulin prompts fat and muscle cells to absorb glucose.
The novel finding by Freddy Yip was published online today in the prestigious international journal, Cell Metabolism.
"Since the 1920s,... read more
Submitted by BarryE
Sugar is naturally present in the blood in the form of glucose and is stored in the liver or adipose tissue (fat) thanks to the action of insulin. Glucose is stored or directly used to ensure satisfactory function of the heart, brain and so on according to the body's demands.
In certain cases, this mechanism may deteriorate either because insulin is no longer produced (type 1 diabetes), or because the receptors located on the... read more
Submitted by BarryE
Skipping breakfast increases our risk as much as 50 percent, and watching TV for two or more hours per day boosts it 14 percent, according to Fitness.
Pam O'Brien, the magazine's article director, says the main reason for the story was to point out that people can lower their risk in about a month.
As a former no-breakfast type, Ms. O'Brien began forcing herself to eat breakfast a few years ago and has... read more
Submitted by Avera
BRIDGEWATER, N.J., Oct 29, 2008 /PRNewswire-FirstCall via COMTEX/ -- Sanofi-aventis announced today that the U.S. Food and Drug Administration (FDA) approved Apidra(R) (insulin glulisine [rDNA origin] injection) to improve glycemic control in children (4 years and older) with diabetes mellitus.
The approval of Apidra(R) for pediatric use is based upon FDA review of a 26-week, phase III, open-label, active control study of Apidra(R) in comparison with insulin lispro, in 572 children and adolescents (4... read more
Submitted by Avera
The overall cost of drugs for type 2 diabetes almost doubled between 2001 and 2007, yet whether these newer drugs improve care and outcomes isn't known, a new study finds.
Submitted by Amy Tenderich